Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma

$491,448ZIAFY2024TRNIH

National Center For Advancing Translational Sciences

Investigators

Juan Marugancontact

Linked publications, trials & patents

Patent 9008391 Patent 9002085 Patent 8885901 Patent 8879813

View original record on NIH RePORTER →

Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma · GrantIndex